PLoS ONEplosplosonePLoS ONE1932-6203Public Library of ScienceSan Francisco, USA09-PONE-RA-08349R110.1371/journal.pone.0006335Research ArticleGenetics and Genomics/Gene ExpressionPhysiology/Cell SignalingPhysiology/Muscle and Connective TissuePhysiology/PhysiogenomicsSex Differences in Global mRNA Content of Human Skeletal MuscleSex Difference in mRNA ContentMaherAmy C.1FuMinghua H.2IsfortRobert J.4VarbanovAlex R.4QuXiaoyan A.4TarnopolskyMark A.3*Department of Medical Sciences, McMaster University, Hamilton, Ontario, CanadaDepartment of Kinesiology, McMaster University, Hamilton, Ontario, CanadaDepartment of Pediatrics and Medicine, McMaster University, Hamilton, Ontario, CanadaProcter and Gamble Pharmaceuticals, Mason, Ohio, United States of AmericaButlerGeraldineEditorUniversity College Dublin, Ireland* E-mail: tarnopol@mcmaster.ca
Conceived and designed the experiments: ACM MAT. Performed the experiments: ACM MHF RJI. Analyzed the data: ACM MHF ARV XAQ. Contributed reagents/materials/analysis tools: RJI MAT. Wrote the paper: ACM. Provided funding: MAT. Edited the paper: MAT.
The authors have declared that no competing interests exist.
2009227200947e6335231200922620092009Maher et alThis is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Women oxidize more fat as compared to men during endurance exercise and several groups have shown that the mRNA content of selected genes related to fat oxidation are higher in women (e.g. hormone sensitive lipase, β-hydroxyacyl-CoA dehydrogenase, CD36). One of the possible mechanisms is that women tend to have a higher area percentage of type I skeletal muscle fibers as compared with men. Consequently, we hypothesized that sex would influence the basal mRNA and protein content for genes involved in metabolism and the determination of muscle fiber type. Muscle biopsies from the vastus lateralis were collected from healthy men and women. We examined mRNA content globally using Affymetrix GeneChips, and selected genes were examined and/or confirmed by RT-PCR. Furthermore, we examined protein content by Western blot analysis. Stringent gene array analysis revealed 66 differentially expressed genes representing metabolism, mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation. Stringent gene array analysis and RT-PCR confirmed that mRNA for; acyl-coenzyme A acyltransferase 2 (ACAA2), trifunctional protein β (HADHB), catalase, lipoprotein lipase (LPL), and uncoupling protein-2 (UCP-2) were higher in women. Targeted gene analysis revealed that myosin heavy chain I (MHCI), peroxisome proliferator-activated receptor (PPAR)δ were higher in women compared with men. Surprisingly, there were no significant sex based differences in protein content for HADHB, ACAA2, catalase, PPARδ, and MHC1. In conclusion, the differences in the basal mRNA content in resting skeletal muscle suggest that men and women are transcriptionally “primed” for known physiological differences in metabolism however the mechanism behind sex differences in fiber type remains to be determined.
Dr. Tarnopolsky is partially supported by an endowed chair from Michael DeGroote and Hamilton Health Sciences Foundation. Some of the equipment used in the analysis was purchased from a donation from Warren Lammert and Kathy Corkins. This study was supported by an NSERC grant to MA Tarnopolsky. AC Maher was supported by an NSERC fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.Introduction
Skeletal muscle is the most abundant tissue in the human body [1], and there are major differences between women and men in energy metabolism, fiber type composition, and contractile speed [2], [3], [4]; however, the mechanisms behind these differences are unknown. A number of groups have reported differences in exercise related substrate metabolism between men and women, specifically that women oxidize more lipid and less carbohydrate than men [5], [6], [7], [8], [9], [10], [11]. Similar studies in rats have also found gender differences in lipid metabolism, specifically that female rats have greater lipid oxidation and muscle lipoprotein lipase (LPL) activity, as compared with male rats [12], [13]. Furthermore, when female rats are oophorectomized, lipid oxidation is lower during endurance exercise [14]. The exact mechanisms behind such observations are unclear; however, sex differences in mRNA content and protein expression appear to be directionally consistent with the observed metabolic differences present during exercise. Specifically, women compared to age and fitness matched men have higher mRNA content for LPL [15], membrane fatty acid transport protein 1 (FATm) [16], FAT/CD36 transporter and plasma membrane fatty acid binding protein (FABPpm) [15], citrate synthase [17], β-hydroxyacyl-CoA dehydrogenase (β-HAD) [17], and hormone sensitive lipase [11]. On the whole body level, women show greater lipolysis [5], [18], and greater uptake of plasma free fatty acids [18], and use more intramuscular triacylglycerol [11], [19], [20] than men.
Futhermore, a sex difference in muscle fiber composition has been found in different skeletal muscles, such as, erector spinae[21], internal and external intercostal, latissimus dorsi[22], biceps brachii[23], vastus medialis[24], and vastus lateralis[5], [25], [26], [27], [28], [29], [30]. Although studies concerning sex differences in skeletal muscle fiber type have shown inconsistent results [4], [25], [26], [28], [29], [31], [32], women generally have a greater relative type I fiber area [4], [5], [26], [27], [30], a smaller relative area of type II fibers and a greater percentage area of type I fibers [4], [5], [26], [27], [28], [32]. The potential molecular mechanisms behind these sex differences have not been evaluated for the mRNA species of the genes involved in muscle development, or fiber-type determination and differentiation.
The molecular mechanisms for the observed differences in substrate oxidation and fiber type between men and women are unknown. In this study we used a targeted approach (RT-PCR) to evaluate mRNA species of the genes involved in muscle development, fiber-type determination and differentiation, and a microarray comparison to evaluate the many more potential mRNA species that are required for lipid metabolism and fiber type in human skeletal muscle, which may yield important data for understanding potential novel mechanisms. Gene array technology has provided a rapid and efficient way to screen a large number of mRNAs in order to identify potential targets and pathways for further research. Recently, several groups have used gene arrays to identify novel transcriptional programs related to human muscle repair, inflammation, protein synthesis and cellular control in skeletal muscle after various interventions such as exercise [33], [34], [35], immobilization [36], and drug treatments [37]. A few groups have done targeted gene expression profiles to examine sex differences in humans [38], [39] and mice [40]. In this study, skeletal muscle biopsies from healthy, young men and women were analyzed for mRNA abundance of over 23,000 genes by Affymetrix gene array analysis with an a priori hypothesis that mRNA species involved in lipid oxidation, muscle development, and fiber-type determination and differentiation would be different in women compared with men. Furthermore, we hypothesized that this global analysis would identify novel mRNA targets that are relevant to biological pathways that differ in skeletal muscle between men and women.
Materials and MethodsParticipants
These studies were approved by the Human Research Ethics Board of McMaster University. The present study used muscle samples from two different studies that recruited subjects using identical criteria and subject characteristics were not significantly different (Table 1). All subjects were between the ages of 18 and 35, healthy, recreationally active, and non-smokers. Highly trained athletes were excluded from the studies. All female participants were eumenorrheic. The present study only compared muscle samples collected at baseline (before manipulation) thus termed “resting muscle” from the two studies. In study 1, 14 women and 13 men volunteered to participate but we only used samples from 12 women and 12 men. Subject characteristics have been previously published [30] but can be viewed in Table 1. In study 2, 24 healthy, recreationally active men (n = 11) and women (n = 13) participated [41]. Data from these subjects regarding diet, CHO, protein and fat oxidation has been previously reported [41], and demonstrated that women had higher fat oxidation and lower protein and carbohydrate oxidation during endurance exercise as compared with men. The muscle samples collected pre-exercise were used for the present study and only samples from women in the follicular phase of their menstrual cycle were used as there was little difference in mRNA content of metabolic related genes between follicular and luteal phase women (Figure S1) compared to differences due to sex (Figure S2) (unpublished data). Study 1 samples were used to acquire the gene array data, histochemical data is a combination of a representative subset of subjects from both studies, and RNA and protein data was acquired from study 2 samples. A comparison of subject characteristics is reported in Table 1. All study participants gave written consent to participate in the study.
10.1371/journal.pone.0006335.t001
Subject characteristics from study #1 and study #2.
Study #1
Study #2
Men (n = 12)
Women (n = 12)
Men (n = 11)
Women (n = 13)
Age (yr)
21±1
22±1
21±1
22±2
Weight (kg)
79±4
61±2*
80±3
63±2*
Height (cm)
179±2
164±1*
178±1
165±1*
BF (%)
18±1
25±1*
19±5
29±5*
FFM (kg)
64±3
44±1*
59±1
52±1*
BMI
25±1
23±1
25±1
23±1
VO2peak (ml*kg body wt-1*min-1)
NA
NA
45±1
39±2*
(ml*kg FFM-1*min-1)
NA
NA
56±1
54±3
Menstral cycle
7 = Fol, 5 = Lut
Fol
Oral Contraceptive use
6 = OC, 6 = NOC
6 = OC, 7 = NOC
Feeding state
Boost® 2 hrs before biopsy
Fasted (10–12 hrs)
significant difference between men and women for each study (P<0.05). There is no significant difference between the men or the women in study 1 compared with study 2. BF; body fat, BMI; body mass index, Fol; follicular phase, Lut; luteal phase, OC; oral contraceptives.
Acquisition of muscle samples
Muscle samples were obtained from the vastus lateralis muscle, ∼15 cm proximal to the lateral knee joint line, using a custom suction-modified Bergstrom needle. Biopsies were taken at rest and all subjects refrained from any exercise for at least 3 days before the muscle biopsy. All biopsies were completed in the morning. Approximately 60 mg of muscle tissue was divided and snap-frozen in liquid nitrogen and stored in a −80°C freezer for RNA and protein analysis.
Histochemical analysis
Histochemical analyses were conducted on samples from study 1and 2, as described by Yasuda et al. [30]. Briefly, the OCT mounted muscle samples were serially sectioned to 10 µm thickness, and slides were preincubated at a pH value of 4.60 in 50 mM potassium acetate, 17.5 mM calcium chloride for 7 min. Slides were rinsed with distilled, deionized water (ddH20) between each of the following steps. Slides were incubated in 3 mM ATP using an alkaline solution (75 mM glycine, 40.5 mM calcium chloride, 75 mM NaCl, 67.5 mM NaOH, pH 9.4) for 45 min at 37°C with agitation at regular intervals. They were incubated consecutively in 1% CaCl2 and 2% CoCl2 for 3 min, and then incubated in 1% ammonium sulphide for 30 s at room temperature. Sections were photographed at 200× magnifications with a microscope (Olympus America Inc., Melville, NY) in conjunction with a SPOT digital camera (Model: SP401-115, SPOT Diagnostic Instruments Inc., MI). Based on the staining intensity at pH 4.60, the three fiber types were classified as Type I (dark), IIa (light) and IIx (intermediate). Cross-sectional areas of the muscle fibers (µm2) were determined using an image analysis program (Image Pro, V6.0, Media Cybernetics Inc., Silver Spring, MD).
Microarray Preparation
Muscle samples from study 1 were used to extract RNA, and the RNA was prepared according to Affymetrix recommendations (Santa Clara, CA). In brief, muscle samples were homogenized in TRIzol Reagent (Life Technologies, Rockville, MD) by shaking in a mixer mill with tungsten carbide beads as recommended by the manufacturer (Qiagen, Life Technologies, Rockville, MD). RNA was purified using an RNeasy Mini Kit (Qiagen, Chatsworth, CA). Ten micrograms of purified RNA was reverse transcribed using SuperScript II Reverse Transcriptase and T7-(dT)24 primer followed by second strand DNA synthesis as per the manufacturer's instructions (Life Technologies, Rockville, MD). Contaminants were removed from the samples by phenol-chloroform-isoamyl alcohol extraction, and the clean cDNA was recovered by ethanol precipitation, using a RNA Transcript Labeling Kit (Enzo Diagnostics, Farmingdale, NY), it was further converted into biotin-labeled cRNA, as per manufacturer's instructions. Moreover, cRNA was purified using a RNeasy Mini Kit (Quiagen, Life Technologies, Rockville, MD) and fragmented in pieces <200 bases by incubation in fragmentation buffer. Samples were stored at −20°C until hybridization.
Samples were hybridized on human HG-U133 Plus 2.0 Arrays using protocols as recommended by Affymetrix (Affymetrix, Santa Clara, CA). In brief, 24 gene chips were used to compare 12 women to 12 men. Biotinylated cRNA was hybridized for 16 h at 45°C in a GeneChip Hybridization Oven 640. Arrays were placed in a GeneChip Fluidic Station 400 for a series of washes, followed by incubation with streptavidin-conjugated phycoerythrin. Finally, arrays were scanned with a GeneArray Scanner (Agilent, Palo Alta, CA) and analyzed using GeneChip Analysis software (Affymetrix, Santa Clara, CA).
Statistical Analysis of MicroArray
The statistical analysis was based on the Affymetrix signal (MAS 5.0 algorithm). Exploratory statistical tools were used to check data quality. There were no quality control problems with the data. The data was then filtered based on the given algorithms for gene content levels, which filtered out genes that have low content levels compared to background (Affymetrix Absent Calls). When a minimum of 19 out of 24 gene replicates read as Affymetrix Absent Calls, the gene is filtered out. An ANOVA model with log (base 2) of the Affymetrix signal as a response is fitted for each one of the genes that are not filtered based on Affymetrix Absent Calls. Significant differential content is calculated by the NLOGP (−log10(P-value)). A gene was considered to be differentially expressed if the NLOGP measure was greater than the 4, and the fold change was at least 1.2. Table S1. Proctor and Gamble use these criteria for their Affymetrix gene array analyses [42]. The negative log of the p value (NLOGP) was calculated from (−log10 (NLOGP 4 = p value threshold of 0.0001), where the p value is a summary measure of the statistical significance for the corresponding comparison.
Gene annotation and functional analysis
Gene function and characterization information was obtained from the Affymetrix website: http://www.affymetrix.com/analysis/index.affx. Further description was obtained from various databases at the National Center for Biotechnology Information. iPath™ (Invitrogen) was used to compared differentially regulated genes against 225 signaling and metabolic human biological pathway maps created for Invitrogen™ by GeneGo. (http://escience.invitrogen.com/ipath). Differentially regulated gene were also run against a Connectivity Map, which is a gene expression database with statistical scoring algorithm to link drug treatment, genes, and diseases.
All gene array data can be accessed via Gene Expression Omnibus (GEO) http://www.ncbi.nlm.nih.gov/geo/. Accession #GSE14901. The data used for this study were the PRECAST values (Table S1) only from a larger study “Limb immobilization induces a coordinate down-regulation of mitochondrial and other metabolic pathways in men and women”.
RNA isolation for RT-PCR
Muscle biopsy samples from study 2 were used to isolated RNA as described previously[43]. Briefly, frozen muscle was thawed in a Tenbroeck homogenizer with 1 ml of TRIzol reagent (Invitrogen, Carlsbad, CA) and homogenized on ice. The homogenate was extracted with 200 µl of chloroform. The aqueous phase was removed and the RNA was precipitated at room temperature using 500 µl of iso-propanol and washed twice with 75% ethanol. The final RNA pellet was air dried at room temperature and resuspended in 14 µl ddH2O and treated with DNaseI. The RNA samples were quantified by spectrophotometer (A260/A280 ≥1.5) and the quality was assessed by agarose gel electrophoresis.
TaqMan® Real-time RT-PCR
TaqMan® real-time RT-PCR was conducted on total RNA. Duplex RT-PCR was performed using an iCycler real-time PCR system (Bio-Rad Laboratories, Hercules, CA). One-step TaqMan® RT-PCR Master Mix Reagent (Roch, Branchburg, New Jersey) was combined with RNA, target gene primers and probes, and internal standard gene primers and probes in the same reaction. Specific primers and probes to each target gene were designed based on the cDNA sequence in GenBank (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) with primer 3 designer (http://frodo.wi.mit.edu/cgi-bin/primer3/primer3www.cgi.). Their specificity was monitored using Blast (http://www.ncbi.nlm.nih.gov/BLAST/). Primer sequences are listed in Table 2.
10.1371/journal.pone.0006335.t002
Primer Sequences.
Gene Name
Forward Primer
Reverse Primer
beta2-microglobulin
ggctatccagcgtactccaa
gatgaaacccagacacatagca
Catalase
actgaggtccaccctgactac
tcgcattcttaggcttctca
Lipoprotein Lipase (LPL)
gaaaggcacctgcggtatt
catgccgttctttgttctgta
Uncoupling protein-2 (UCP-2)
tcatcacctttcctctggatac
agaatggtgcccatcacac
Acyl-coenzyme A acyltransferase-2 (ACAT2)
ggcaggagaagcaagatga
gcaccattgaaggaacctatg
Aldehyde dehydrogenase 1 family member A1 (ALDH1A1)
cgccagacttacctgtcctact
ctcctcagttgcaggattaaag
Trifunctional protein β subunit (HADHB)
aaacaagcaatgtggctagaga
ggcttggttggcagagatac
Myosin Heavy Chain I (MHCI)
cctggaacatctggagacct
agctgctttcggaccttct
Myosin Heavy Chain IIa (MHCIIa)
caatctagctaaattccgcaagc
tcacttatgacttttgtgtgtgaacct
Myosin Heavy Chain IIx (MHCIIx)
aaatggtggaaagaagagagtcc
aatacagcttcatccagggc
PGC-1alpha
ttgctaaacgactccgagaa
tgcaaagttccctctctgct
PPARdelta
actgagttcgccaagagcat
gtgcacgccatacttgagaa
Myostatin
gacccgtcgagactcctaca
aataccagtgcctgggttca
All primer sequences are shown 5′ to 3′, left to right.
All probes were dual-labeled with fluorophores, with a fluorescent reporter dye at the 5′ end (FAM, TET, HEX or TAMRA) and a corresponding quencher dye at its 3′ end (3BHQ-1 or 3BHQ-2). Human β2- microglobulin (β2-M) was used as an internal standard as there was no significant sex difference in expression (data not shown). All samples were run in duplicate simultaneously with RNA- and RT-negative controls. Fluorescence emission was detected through a filter corresponding to the reporter dye at the 5′end of each probe, and CT was automatically calculated and displayed.
Western blot analysis
Thirty mg of tissue was used for protein content analysis. Muscle tissue was homogenized in a phosphate lysis buffer; 50 mM K2HPO4, 1 mM EDTA, pH 7.4, 0.1 mM DDT, PhosSTOP (Roach Diagnostics, Mannheim, Germany), Protease inhibitor cocktail tablets (Roach). Protein concentrations were calculated by Bradford assay (Biorad) and equal amounts of protein were boiled in Laemmli buffer, resolved by SDS-PAGE, transferred to nitrocellulose paper and immunoblotted with desired antibodies. Primary antibodies; HADHB, ACAA2, catalase, PPARδ, MHC I, MHC II and β-actin were all purchased from (Abcam, Cambridge, MA). Secondary antibodies conjugated to horseradish peroxidase (Amersham Bioscience, UK) and specific antibody binding was detected using the chemiluminescence detection reagent ECL+ (Amersham BioScience, UK). Scanned films were analyzed using ImageJ 1.40 software (Wayne Rasband National Institute of Health, USA).
Statistical analysis
All statistical analyses, for mRNA content of the genes, was performed on linear data 2−CT for evaluation of internal standards, 2−ΔCT for target gene normalized with internal reference [44]. Data on sex differences about target gene mRNA content were analyzed using a Student's t test. All results from evaluation of target gene are expressed as mean±SEM, using 2−ΔCT. Western blot data was normalized by the loading control (β-actin) and a Student's t test was preformed to test for a difference between men and women. Data are presented as means±SEM. The data regarding muscle fiber composition were analyzed using a single factor ANOVA and expressed as mean±SEM. All analyses were done using statistics software (Statistica version 5.0; Statsoft, Tulsa, OK). Statistical significance was set at α≤0.05.
ResultsSex alters mRNA content in skeletal muscle; microarray
The mRNA abundance in skeletal muscle between men and women was significantly different for 66 genes (using a stringent NLOGP≥4, fold-change>1.2), after Y-linked genes were removed (Table 3; GEO accession #GSE14901). Of these 66 genes, 49 genes have known functions in metabolism, mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation (Table 3). Conversely, 17 of the genes identified in the current analysis do not have known functions. Of the 49 genes with known function, women had higher content of 25 genes (mean 1.7±0.4), compared to men. Subsequently, women have lower content of 24 genes (mean −2.1±2.0), compared to men.
10.1371/journal.pone.0006335.t003
Differential expression of mRNA in women vs men.
Gene Name
Symbol
Fold Change
NLOGP
Biological Process
Metabolism
hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), beta subunit
similar to Caspase-4 precursor (CASP-4) (ICH-2 protease) (TX protease) (ICE(rel)-II)
LOC648470
1.9
4.50
proteolysis
JTV1 gene
JTV1
−1.42
5.80
protein biosynthesis
ubiquitin specific peptidase 31
USP31
−1.42
4.10
ubiquitin-dependent protein catabolism
ring finger and CHY zinc finger domain containing 1
RCHY1
−1.31
5.10
ubiquitin cycle
ADP-ribosylhydrolase like 1
ADPRHL1
−1.61
4.70
protein amino acid ADP-ribosylation
Cell Proliferation
zinc finger protein 36, C3H type-like 2
ZFP36L2
1.48
4.80
cell proliferation
monocyte to macrophage differentiation-associated
MMD
1.67
4.10
cytolysis
angiopoietin 1
ANGPT1
1.74
4.30
angiogenesis, signal transduction, cell differentiation, development
plexin C1
PLXNC1
1.94
4.70
cell adhesion, development
cell division cycle associated 7-like
CDCA7L, RAM2
2.45
4.40
positive regulation of cell proliferation
tumor protein D52
TPD52
−1.72
5.70
morphogenesis, B cell differentiation, secretion
Down syndrome critical region gene 1-like 1
DSCR1L1
−1.67
5.90
central nervous system development, calcium-mediated signaling
cytokine induced apoptosis inhibitor 1
CIAPIN1
−1.31
4.90
apoptosis, anti-apoptosis
CD24 molecule
CD24
−4.19
7.00
humoral immune response
dishevelled associated activator of morphogenesis 2
DAAM2
−1.71
4.20
actin cytoskeleton organization and biogenesis
attractin-like 1
ATRNL1
−1.83
4.80
development
spectrin, beta, non-erythrocytic 1
SPTBN1
−1.52
5.30
barbed-end actin filament capping
UNKNOWN
ubiquitously transcribed tetratricopeptide repeat, X chromosome
UTX
2.13
9.35
---
zinc finger, BED-type containing 5
ZBED5
−1.31
4.30
---
Nedd4 family interacting protein 2
NDFIP2
−1.4
4.60
---
chromosome 2 open reading frame 25
C2orf25
−1.23
4.00
---
tryptophan rich basic protein
WRB
−1.47
6.00
---
PQ loop repeat containing 3
PQLC3
1.77
4.30
---
CDNA FLJ25488 fis, clone CBR00232
---
−1.34
5.20
---
family with sequence similarity 79, member B
FAM79B
5.94
8.80
---
X (inactive)-specific transcript
XIST
192.07
32.77
---
CDNA FLJ33569 fis, clone BRAMY2010317
---
−1.47
4.00
---
hypothetical protein
LOC387882
3.04
5.30
---
chromosome 8 open reading frame 22
C8orf22
2
4.20
---
chromosome Y open reading frame 15A
CYorf15A
−2.01
5.10
---
KIAA1155 protein
KIAA1155
1.71
5.10
---
Prader-Willi syndrome chromosome region 1
PWCR1
−1.61
5.00
---
Heparan-alpha-glucosaminide N-acetyltransferase, similar to transmembrane protein 76
HGSNAT, LOC643642
1.53
5.30
---
hypothetical gene CG018
CG018
1.61
6.60
---
Microarray significance >1.2 fold increase or decrease. NLOGP, negative log of the p value, >4.0. N = 12 men and 12 women.
iPath™ (Invitrogen) was used to compared differentially regulated genes against 225 signaling and metabolic human biological pathway maps, and these gene were found to be involved in 39 different signal transduction pathways. Differentially regulated genes were also run against a Connectivity Map to compare the expression profile to that of known drug treatments, genes, and diseases. Interestingly, differentially expressed genes between genders were found to share a similar expression pattern with the transcript profiling of estradiol (which is estrogenic), genistein (which could be estrogenic or anti-estrogenic) and tretinoin (a vitamin A derivative) drug treatments.
Sex alters mRNA content of genes involved metabolism and mitochondrial biogenesis
Sex altered content of six genes involved in metabolism and three genes involved in the function of mitochondria and energy production (Table 3). HADHB (trifunctional protein β), ACAA2, LPL, UCP-2, catalase, aldehyde dehydrogenase 2 family (ALDH2), and argininosuccinate synthase 1 (ASS1) all had higher mRNA content in women compared to men by 1.3- to 2.2-fold. ALDH1A1 and ATP synthase mitochondrial F1 complex assembly factor 1 were significantly lower in women compared to men by 1.9 fold and 1.5-fold respectively (Table 3).
The mRNA content of genes involved in lipid metabolism, HADHB, ACAA2, and catalase, were confirmed by real time RT-PCR (Figure 1, 2a, 3a, 4a) using study 2 samples. The mRNA content of UCP-2, LPL, and ALDH1A1 were also confirmed by real time RT-PCR (Figure 1, 5), and fold-change of the RT-PCR results correlated to the fold-change reported by the microarray (Figure 1).
10.1371/journal.pone.0006335.g001
Comparison of microarray data to RT-PCR results for 6 genes found to be significantly different between men and women.
Shown as fold change in women versus men. N (microarray) = 12 men, 12 women; N (RT-PCR) = 12 men, 12 women.
10.1371/journal.pone.0006335.g002
Sex differences in HADHB.
Differences in HADHB muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of HADHB in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g003
Sex differences in ACAA2.
Differences in ACAA2 muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of ACAA2 in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g004
Sex differences in catalase.
Differences in Catalase mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of catalase in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g005
Skeletal muscle mRNA content of LPL, UCP-2 and ALDH1A1 in men and women.
LPL is higher in women than men (P = 0.009) (A). UCP-2 is higher in women than men (P = 0.05) (B). ALDH1A1 is lower in women than men (P = 0.01) (C). β2-M mRNA was used as an internal standard. N = 12 men and 12 women.
To determine if sex differences in mRNA content were consistent with protein content we resolved HADHB, ACAA2, and catalase on a western blot and found no significant difference in protein content between men and women (Figure 2c, 3c, 4c;study 2 samples).
Sex difference in muscle fiber composition
Fiber composition data for a subset of study 1 subjects has been published previously [30]. Fiber composition data for a subset of study 2 subjects was compared to study 1 and when no differences were observed the data was combined to increase the n-value and the data is presented in table 4. Fiber data was consistent with other published data [4], [5], [26], [27] showing women had a significantly higher area% of Type I fibers (women, 32.9±1.3; men, 27.3±1.0; P = 0.001) and a significantly lower area% of Type II fibers (type IIa+type IIx) (women, 67.1±1.3%; men, 72.7±1.0%; P = 0.001) than men (Table 4). Women had significantly smaller mean individual fiber area for type IIa (women, 4777.2±347.8 µm2; men, 6066.9±408.3.8 µm2; P = 0.013), while there was no significant difference in the type I fiber area or type IIx between women and men (Table 4).
10.1371/journal.pone.0006335.t004
Fiber type composition in the vastus lateralis muscle of women and men.
Men (N = 10)
Women (N = 16)
Fiber type composition (area%)
Type I
27.3±1.0
32.9±1.3 *
Type IIa+IIx
72.7±1.0
67.1±1.3 *
Mean area per fiber (µm2)
Type I
4218.6±225.0
4691.7±477.9
Type IIa
6066.9±408.3
4777.2±347.8 *
Type IIx
5208.7±220.3
4677.7±389.8
Sex differences in fiber type composition between men and women. Due to experimental difficulties data is a combined subset of samples from both study #1 and study#2. Means±SEM *P<0.05.
Sex differences in mRNA content for genes involved in muscle type determination
The stringent microarray analysis revealed no significant genes related to muscle type determination. A more biased targeted RT-PCR approach resulted in the content of MHCI mRNA being significantly higher in the skeletal muscle of women (2.6±0.7 fold, P = 0.035) than men (Figure 6a). No significant difference in the mRNA content of MHCIIa or MHCIIx was found between women and men (Figure 6c,d). Women had a significantly higher mRNA content of PPARδ than men (2.3±0.4 fold, P = 0.004) (Figure 7a). There were no significant differences in the mRNA content of PGC-1α or myostatin in the skeletal muscle of men vs. women (Figure 8a, 9a). Western blot analysis showed no significant sex difference in the protein content of MHC I, MHC II, PPARδ, PGC-1α or myostatin (Figure 6b,e, 7c, 8c, 9c). *All data was acquired from study 2.
10.1371/journal.pone.0006335.g006
Sex differences in MHC isoforms.
Differences in MHC I muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to 28 S rRNA (A). Protein content of MHCI in skeletal muscle of men and women, adjusted to β-actin (B). MHC IIa (C) and MHC IIx (D) muscle mRNA content in men and women shown by Real time RT-PCR, adjusted to 28 S rRNA. Protein content of MHC II in skeletal muscle of men and women (E). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g007
Sex differences in PPARδ.
Differences in PPARδ muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of PPARδ in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g008
Sex differences in PGC1α.
Differences in PGC1α muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of PGC1α in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women. *P<0.05.
10.1371/journal.pone.0006335.g009
Sex differences in myostatin.
Differences in myostatin muscle mRNA content between men and women shown by Real time RT-PCR, adjusted to β2-M mRNA (A). Protein content of myostatin in skeletal muscle of men and women, adjusted to β-actin (B,C). Lanes 1–4 are men, lanes 5–8 women, representative of all blots. N = 12 men and 12 women.
Discussion
The purpose of this study was to identify novel differences in genes related to metabolism, muscle development, and fiber-type determination and differentiation in mRNA and protein content in skeletal muscle between men and women at rest using microarray, Real Time-PCR analysis, and protein analysis. Microarrays are a useful tool for the identification of novel mRNA expression patterns and can help to understand potential pathways involved in regulating cellular activity in skeletal muscle [33], [38], [45], [46]. The results from these studies indicate that there are significant differences in mRNA content between men and women. Roth et al. (2002) and Welle et al. (2008) have previously shown that there are significant differences in skeletal muscle mRNA content between men and women, as well as showing sex differences are significantly greater than age and/or strength training effects on mRNA content [38], [39]. Approximately 30% of the genes we found to have changed due to sex correspond to the results of Welle and colleagues [39]. Results likely vary between studies due to differences in age of the subject populations, fitness variations, low sample numbers, pooled samples on one gene chip versus individual gene chips per subject, and different gene array technology [38], [39]. The methodology used in this study greatly strengthens the data regarding sex based differences in skeletal muscle mRNA for we examined over 23,000 genes with updated annotation, with 12 subjects per group (N = 24 total) hybridized to individual gene chips for analysis and used stringent statistical analysis with an NLOGP>4. The criteria for differential expression is stringent compared to other array studies that generally use an NLOGP>2, however, necessary for the most accurate unbiased account of gene content differences. For the microarray experiment we used samples from study one which included 7 women in the follicular phase and 5 women in the luteal phase, 6 on oral contraceptives and 6 not on oral contraceptives which gives a good representation of the female population. Given the high n-value of the analysis and stringent array analysis criteria we wanted to reduce any variability in gene expression due to these factors in order to only identify specific and significant gene differences that can be applied to a larger population. The goal of the microarray was not to identify genetic differences due menstrual cycle phase but identify sex related differences between an average population of men and women. In another manuscript “in preparation” from study 2 we used a targeted PCR approach to examine differences in metabolic related genes in men compare to women in both the follicular and luteal phases of the menstrual cycle and found that menstrual cycle had little effect on metabolic related mRNA species, compared to the robust difference that sex has (Figures S1 and S2). Due to these findings, the little amount of precious human muscle sample, and the relatively consistent use of follicular phase women in other gender related studies [5], [11], [17], [18], [19], [20], [47] we compared the mRNA and protein of women in the follicular phase only. It is also important to note that Devries et al (2006) report no physiological difference in exercise performance due to menstrual cycle phase including average RER, glycogen utilization, glucose rate of appearance, rate of disappearance, and metabolic clearance rate averaged over the exercise period [41].
The first focus was on the mRNA content of genes involved in intermediary substrate metabolism due to the known fact that women oxidize more fat during endurance exercise as compared with men [5], [6], [7], [8], [10], [11], [48]. Array results identified six genes related to metabolism that were differentially regulated between men and women. We chose to confirm the mRNA content of five of these genes by RT-PCR. Results identified a novel sex-based difference in the mRNA content of ACAA2 and HADHB (TFP-β). Also, the mRNA content for catalase, lipoprotein lipase, and uncoupling protein-2 were higher in women compared with men. Lastly, ALDH1A1 mRNA content was lower in women compared with men. There was also sex based differences in the mRNA content of genes involved in protein biosynthesis, cell proliferation, signal transduction, transcription, and translation with a particular interest in those genes which are directly involved in muscle function and/or structure.
HADHB (TFPβ) is a multi-enzyme complex found in the mitochondria that is involved in the β-oxidation of fatty acids [49]. Specifically, the TFP enzyme catalyzes the last three steps of long chain fatty acid β-oxidation for long-chain specific acyl-CoA moieties. We are the first to measure and report a sex difference in the mRNA content for this gene. An enhanced β-oxidation capacity distal to transport of FFA into the mitochondria may allow for maintenance of β-oxidation when the cell is under metabolic stress. For example, male transgenic peripheral peroxisome activating receptor knockout (PPARα−/−) animal develop severe hypoglycemia when an inhibitor of CPT activity (etomoxir) was given, yet the majority of female mice survived [50]. Furthermore, CPTII deficiency is an autosomal recessive condition and yet many more cases have been documented in men as compared with women, possible due to enhanced β-oxidation capacity in women. Others have reported that the short-chain specific isoform of HAD (SCHAD) has higher mRNA and protein abundance in women compared with men [2], [51].
These results also indicate a significant sex based difference in the mRNA content of ACAA2 (acetyl-Coenzyme A acyltransferase 2). ACAA2 is one of two isoforms of ACAA, which is an intracellular enzyme that biosynthesizes cholesteryl esters. Specifically, ACAA is involved in storing cholesteryl esters as lipid droplets, in absorbing dietary cholesterol, and in providing cholesteryl esters as part of the core lipid for lipoprotein synthesis and assembly [52], [53], [54]. Although ACAA appears to be present in many cell types such as hepatocytes, adrenal cells, skin cells, intestinal enterocytes, neurons, and macrophages it has not been well characterized in skeletal muscle [55], [56]. In the aforementioned cell types it has been shown that the ACAA1 isoform is the predominant enzyme compared to ACAA2 [55]. Our gene array results suggest that men and women have no significant difference in the expression of ACAA1 but women have an increased expression of ACAA2 compared to men. Therefore, the total ACAA expression should be significantly higher in women than men, which may explain why lipids are more readily available for substrate utilization during endurance exercise in women. Future studies are needed to determine the expression profile of ACAA1 and ACAA2 in human skeletal muscle as well as the importance of ACAA2 over-expression in women compared to men.
Catalase is one of the three primary antioxidant enzymes. RT-PCR confirmed that mRNA content for catalase is significantly higher in women compared to men. Interestingly, Fano et al (2001) have shown that the enzyme activity of catalase, in the vastus lateralis, is significantly higher in women than men [57]. Sex differences have also been observed in other antioxidant enzyme, including manganese-superoxide dismutase [58], suggesting that women are better protected against reactive oxygen species (ROS) as compared with men. We also demonstrated that mRNA content for UCP2 was higher in women compared to men. UCP's can affect energy metabolism efficiency by uncoupling ATP production from mitochondrial respiration. UCP2 is involved in the regulation of energy metabolism and might play a role in obesity [59], [60], [61]. UCP2 has also been suggested to affect the production of reactive oxygen species (ROS) [62], [63], [64], and regulate the [ATP]/[ADP] ratio [64], [65], [66]. Although we are the first to show a sex specific difference in mRNA content in the vastus lateralis, this may help to explains why young women are protected against ROS (reviewed in [67]). Furthermore, if UCP2 does play a role in obesity the higher expression in women might help to regulate lipid oxidation.
ALDH1A1 is an isoform of the aldehyde dehydrogenase superfamily primarily responsible for the oxidation of endogenous and exogenous aliphatic and aromatic aldehydes including acetaldehyde, benzaldehyde, 4-hydroxynonenal, malondialdehyde, and retinaldehyde [68], [69], [70]. Recently ALDH1A1 was also shown to convert 3-deoxyglucosone into 2-keto-3-deoxygluconate [71]. In this study we found that the mRNA content was lower in women compared with men, suggesting that men might be able to metabolize aldehydes (i.e. alcohol) more efficiently than women. ALDH1A1 has not been well characterized in humans, let alone skeletal muscle, but in the mouse liver and human colon there appears to be no sex differences in activity [72], [73]. Further studies into the implications of ALDH1A1 mRNA sex differences in skeletal muscle need to be conducted.
These results also showed sex specific differences in genes involved in cell transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation. Of interest, women had a 2.2-fold reduction in the solute carrier family 1, member 4 that is involved in glutamate/neutral amino acid transport which could be important in metabolism. Women had a 1.7-fold increase in mRNA content of angiopoietin 1, a factor involved in increasing vascularization to a specific tissue, in this case, muscle; however, there does not seem to be a significant difference in capillarization of the tibialis anterior or vastus lateralis muscle of women compared to men [74], [75]. Women also had a 1.7- and 1.5-fold reduction in Dishevelled associated activator of morphogenesis 2, and spectrin- beta- non-erythrocytic 1 which are involved in actin cytoskeleton organization and biogenesis, and barbed-end actin filament capping, respectively. Both are important in muscle cell shape and function. There was an interesting trend in the expression of signal transduction genes and transcription factor genes. Women had a significant up-regulation of the majority of signal transduction related genes and a significant down-regulation of the majority of transcription factor genes. Despite these trends, there was no evidence that one signal transduction pathway was favored over another as the identified genes spanned multiple pathways including the MAPK pathway, frizzled signaling pathway, G-protein coupled receptor protein signaling pathway, and insulin receptor signaling pathway.
It is important to note that gene array analysis works on the assumption that basal mRNA equates into changes at the protein level and thus activity level. However, recent studies have been demonstrating that is not always the case. For example Kiens et al. (2004) demonstrated that women have a significantly higher LPL mRNA content; however there was no observed differences in LPL activity between men and women [47]. Similarly, Roepstorff et al. demonstrated that although mRNA and protein expression of hormone sensitive lipase (HSL) was higher in women, phosphorylation activation was significantly higher in men [11]. Another study in skeletal muscle biology also found discrepancies in the correlation between mRNA and protein content of a number of genes related to fatty acid oxidation [76]. Part of the discrepancy between mRNA abundance and protein and enzyme assays may relate to higher variance in Western blots and activity assaystechnique, and/or that the transcriptome abundance regulates multiple interacting and synergistic pathways that combine to influence flux through metabolic pathways at the protein level that is below the detectable threshold for statistical changes in a single given protein to be manifested. In order to fully understand cellular differences between men and women it is important to understand pre-translational (mRNA abundance), translational (protein) and post-translational (phosphorylation) levels of control.
It has recently been hypothesized that some of the sex differences in exercise substrate selection may be due to fiber-type compositional differences [32]. Subject fiber type characteristics were the same in this study as previously reported [4], [5], [26], [27], [30], [32]; specifically, the proportionate area (area%) of type I fibers was higher, while that of type II fibers was lower, in women compared with men. Previous findings of a sex difference in type I fiber proportion [25], [28], [29], [32] and a larger type I fiber area [4], [5], [27], [30], in women as compared with men were not confirmed. Nevertheless, it is the proportion of the total muscle area represented by a given fiber type (area X proportion = area%) that should determine the overall abundance of a given transcript or protein in a homogenate of skeletal muscle. Examination of mRNA expression of myosin heavy chain genes, which are specifically expressed in their corresponding muscle fiber types [77], are good markers of the terminal differentiation of muscle fibers. In this study, we found a significantly higher mRNA content of MHCI and a similar mRNA content of MHCIIa and MHCIIx in the skeletal muscles of women compared with men. The difference in MHCI mRNA did not translate into differences in MHCI protein expression, consistent with previous findings [30].
Similarly, we found sex differences in the mRNA content, but not the protein content, of PPARδ; which plays a role in the conversion of muscle fiber type II into type I and maintenance of the number of type I fibers [78], and increases the capacity for oxidative metabolism of muscle fibers through hyperplasia of type I fibers [79], [80] in transgenic mice.
Strong evidence in transgenic mice [81], and controversial evidence in humans [82], [83], [84], suggests that PGC-1α is important in the determination of muscle fiber type and induces a fiber type transformation from type II into type I muscle fibers. We did not find an influence of sex on the mRNA or protein content of PGC-1α in skeletal muscle in spite of the fact that women had a higher% area of type I fibers. We also found that there was no sex difference in the mRNA content of myostatin, a negative regulator of skeletal muscle growth [85], [86], [87].
At rest, there are no significant differences in protein content of the select genes examined, which are involved in metabolism or fiber type. Consistently, there are no observed sex differences in substrate utilization at rest [7], [8], [88], [89], [90]. However, mRNA content suggest that men and women are “primed” differently for specific cellular events, and future studies are need to determine if exercise induces changes at the translational and post-translational levels.
Overall, these results identified sex-based differences in mRNA content of metabolic related genes that might lead the way towards an understanding of the sex-based differences in metabolic fuel selection during endurance exercise. Furthermore, this study emphasizes the importance of the influence of sex based differences in gene expression. At the mRNA level there are no inconsistencies in our data or in the literature, which supports that women have higher mRNA abundance for genes involved in fat metabolism as compared with men. Furthermore, men and women demonstrate varied regulation of genes involved in mitochondrial function, transport, protein biosynthesis, cell proliferation, signal transduction pathways, transcription and translation, even at rest.
Supporting Information
Affymetrix gene array analysis comparing resting human skeletal muscle of women with men. Original Affymetrix data. LogFC; Log fold-change, NLogP;negative log of the p value (>4.0), F; Woman M; Man.
(0.04 MB XLS)
Menstrual cycle differences in resting mRNA content of genes related to substrate metabolism. Genes are expressed as mean fold difference follicular/luteal±SEM. β2-M mRNA was used as an internal standard. N = 12 men and 12 women. *P<0.05.
(1.37 MB TIF)
Sex differences in resting mRNA content of genes related to substrate metabolism. Genes are expressed as mean fold difference women/men±SEM. β2-M mRNA was used as an internal standard. N = 12 men and 12 women. *P<0.05.
(1.83 MB TIF)
We acknowledge Nobuo Yasuda and Elisa Glover for collection of the samples used for the gene array analysis (study 1), and Nobuo Yasuda for histochemical staining. We acknowledge Dr. Mazen Hamadeh for collection of study 2 samples.
ReferencesJanssenIHeymsfieldSBBaumgartnerRNRossR2000Estimation of skeletal muscle mass by bioelectrical impedance analysis.89465471GreenHJFraserIGRanneyDA1984Male and female differences in enzyme activities of energy metabolism in vastus lateralis muscle.65323331KomiPVKarlssonJ1978Skeletal muscle fibre types, enzyme activities and physical performance in young males and females.103210218SimoneauJALortieGBoulayMRThibaultMCTheriaultG1985Skeletal muscle histochemical and biochemical characteristics in sedentary male and female subjects.633035CarterSLRennieCTarnopolskyMA2001Substrate utilization during endurance exercise in men and women after endurance training.280E898907FriedlanderALCasazzaGAHorningMAHuieMJPiacentiniMF1998Training-induced alterations of carbohydrate metabolism in women: women respond differently from men.8511751186HortonTJPagliassottiMJHobbsKHillJO1998Fuel metabolism in men and women during and after long-duration exercise.8518231832TarnopolskyLJMacDougallJDAtkinsonSATarnopolskyMASuttonJR1990Gender differences in substrate for endurance exercise.68302308KiensB1997Effect of endurance training on fatty acid metabolism: local adaptations.29640645RiddellMCPartingtonSLStupkaNArmstrongDRennieC2003Substrate utilization during exercise performed with and without glucose ingestion in female and male endurance trained athletes.13407421RoepstorffCDonsmarkMThieleMVistisenBStewartG2006Sex differences in hormone-sensitive lipase expression, activity, and phosphorylation in skeletal muscle at rest and during exercise.291E11061114EllisGSLanza-JacobySGowAKendrickZV1994Effects of estradiol on lipoprotein lipase activity and lipid availability in exercised male rats.77209215KendrickZVEllisGS1991Effect of estradiol on tissue glycogen metabolism and lipid availability in exercised male rats.7116941699KendrickZVSteffenCARumseyWLGoldbergDI1987Effect of estradiol on tissue glycogen metabolism in exercised oophorectomized rats.63492496KiensBRoepstorffCGlatzJFBonenASchjerlingP2004Lipid-binding proteins and lipoprotein lipase activity in human skeletal muscle: influence of physical activity and gender.9712091218BinnertCKoistinenHAMartinGAndreelliFEbelingP2000Fatty acid transport protein-1 mRNA expression in skeletal muscle and in adipose tissue in humans.279E10721079RoepstorffCSchjerlingPVistisenBMadsenMSteffensenCH2005Regulation of oxidative enzyme activity and eukaryotic elongation factor 2 in human skeletal muscle: influence of gender and exercise.184215224MittendorferBHorowitzJFKleinS2002Effect of gender on lipid kinetics during endurance exercise of moderate intensity in untrained subjects.283E5865SteffensenCHRoepstorffCMadsenMKiensB2002Myocellular triacylglycerol breakdown in females but not in males during exercise.282E634642RoepstorffCSteffensenCHMadsenMStallknechtBKanstrupIL2002Gender differences in substrate utilization during submaximal exercise in endurance-trained subjects.282E435447MannionAFDumasGACooperRGEspinosaFJFarisMW1997Muscle fibre size and type distribution in thoracic and lumbar regions of erector spinae in healthy subjects without low back pain: normal values and sex differences.190 ( Pt 4)505513HardsJMReidWDPardyRLParePD1990Respiratory muscle fiber morphometry. Correlation with pulmonary function and nutrition.9710371044MillerAEMacDougallJDTarnopolskyMASaleDG1993Gender differences in strength and muscle fiber characteristics.66254262HowelD1994Statistical analysis of compositional data in anatomy.240625631BrookeMHEngelWK1969The histographic analysis of human muscle biopsies with regard to fiber types. 1. Adult male and female.19221233Esbjornsson-LiljedahlMSundbergCJNormanBJanssonE1999Metabolic response in type I and type II muscle fibers during a 30-s cycle sprint in men and women.8713261332EsbjornssonMSylvenCHolmIJanssonE1993Fast twitch fibres may predict anaerobic performance in both females and males.14257263SimoneauJABouchardC1989Human variation in skeletal muscle fiber-type proportion and enzyme activities.257E567572StaronRSHagermanFCHikidaRSMurrayTFHostlerDP2000Fiber type composition of the vastus lateralis muscle of young men and women.48623629YasudaNGloverEIPhillipsSMIsfortRJTarnopolskyMA2005Sex-based differences in skeletal muscle function and morphology with short-term limb immobilization.9910851092CostillDLDanielsJEvansWFinkWKrahenbuhlG1976Skeletal muscle enzymes and fiber composition in male and female track athletes.40149154RoepstorffCThieleMHilligTPilegaardHRichterEA2006Higher skeletal muscle {alpha}2AMPK activation and lower energy charge and fat oxidation in men than in women during submaximal exercise.574125138MahoneyDJPariseGMelovSSafdarATarnopolskyMA2005Analysis of global mRNA expression in human skeletal muscle during recovery from endurance exercise.ChenYWHubalMJHoffmanEPThompsonPDClarksonPM2003Molecular responses of human muscle to eccentric exercise.9524852494ZambonACMcDearmonELSalomonisNVranizanKMJohansenKL2003Time- and exercise-dependent gene regulation in human skeletal muscle.4R61UrsoMLScrimgeourAGChenYWThompsonPDClarksonPM2006Analysis of human skeletal muscle after 48 h immobilization reveals alterations in mRNA and protein for extracellular matrix components.10111361148UrsoMLClarksonPMHittelDHoffmanEPThompsonPD2005Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins.2525602566RothSMFerrellREPetersDGMetterEJHurleyBF2002Influence of age, sex, and strength training on human muscle gene expression determined by microarray.10181190WelleSTawilRThorntonCA2008Sex-related differences in gene expression in human skeletal muscle.3e1385YoshiokaMBoivinABolducCSt-AmandJ2007Gender difference of androgen actions on skeletal muscle transcriptome.39119133DevriesMCHamadehMJPhillipsSMTarnopolskyMA2006Menstrual Cycle Phase and Sex Influence Muscle Glycogen Utilization and Glucose Turnover During Moderate Intensity Endurance Exercise.HinkleRTLefeverFRDolanETReichartDLDietrichJA2007Corticortophin releasing factor 2 receptor agonist treatment significantly slows disease progression in mdx mice.518MahoneyDJCareyKFuMHSnowRCameron-SmithD2004Real-time RT-PCR analysis of housekeeping genes in human skeletal muscle following acute exercise.18226231LivakKJSchmittgenTD2001Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.25402408HaslettJNSanoudouDKhoATHanMBennettRR2003Gene expression profiling of Duchenne muscular dystrophy skeletal muscle.4163171SterrenburgETurkRt HoenPAvan DeutekomJCBoerJM2004Large-scale gene expression analysis of human skeletal myoblast differentiation.14507518KiensBRoepstorffCGlatzJFBonenASchjerlingP2004Lipid binding proteins and lipoprotein lipase activity in human skeletal muscle: Influence of physical activity and gender.MelansonELSharpTASeagleHMHortonTJDonahooWT2002Effect of exercise intensity on 24-h energy expenditure and nutrient oxidation.9210451052OriiKEAoyamaTSouriMJiangLLOriiKO1996Formation of the enzyme complex in mitochondria is required for function of trifunctional beta-oxidation protein.219773777DjouadiFWeinheimerCJSaffitzJEPitchfordCBastinJ1998A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator- activated receptor alpha- deficient mice.10210831091GauthierJMTheriaultRTheriaultGGelinasYSimoneauJA1992Electrical stimulation-induced changes in skeletal muscle enzymes of men and women.2412521256RudelLLLeeRGCockmanTL2001Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.12121127JoyceCSkinnerKAndersonRARudelLL1999Acyl-coenzyme A:cholesteryl acyltransferase 2.108995ChangTYChangCCChengD1997Acyl-coenzyme A:cholesterol acyltransferase.66613638ChangCCSakashitaNOrnvoldKLeeOChangET2000Immunological quantitation and localization of ACAT-1 and ACAT-2 in human liver and small intestine.2752808328092SakashitaNMiyazakiATakeyaMHoriuchiSChangCC2000Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues.156227236FanoGMecocciPVecchietJBeliaSFulleS2001Age and sex influence on oxidative damage and functional status in human skeletal muscle.22345351BarreiroECoronellCLavinaBRamirez-SarmientoAOrozco-LeviM2006Aging, sex differences, and oxidative stress in human respiratory and limb muscles.41797809EnerbackSJacobssonASimpsonEMGuerraCYamashitaH1997Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese.3879094BuemannBSchierningBToubroSBibbyBMSorensenT2001The association between the val/ala-55 polymorphism of the uncoupling protein 2 gene and exercise efficiency.25467471BarbePMilletLLarrouyDGalitzkyJBerlanM1998Uncoupling protein-2 messenger ribonucleic acid expression during very-low-calorie diet in obese premenopausal women.8324502453SkulachevVP1998Uncoupling: new approaches to an old problem of bioenergetics.1363100124Negre-SalvayreAHirtzCCarreraGCazenaveRTrolyM1997A role for uncoupling protein-2 as a regulator of mitochondrial hydrogen peroxide generation.11809815ArsenijevicDOnumaHPecqueurCRaimbaultSManningBS2000Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production.26435439SchrauwenPHesselinkM2002UCP2 and UCP3 in muscle controlling body metabolism.20522752285ZhangCYBaffyGPerretPKraussSPeroniO2001Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes.105745755VinaJSastreJPallardoFBorrasC2003Mitochondrial theory of aging: importance to explain why females live longer than males.5549556VasiliouVPappaAPetersenDR2000Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism.129119GagnonIDuesterGBhatPV2002Kinetic analysis of mouse retinal dehydrogenase type-2 (RALDH2) for retinal substrates.1596156162VasiliouVPappaAEsteyT2004Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism.36279299CollardFVertommenDFortpiedJDuesterGVan SchaftingenE2007Identification of 3-deoxyglucosone dehydrogenase as aldehyde dehydrogenase 1A1 (retinaldehyde dehydrogenase 1).89369373MalyIPCrotetVSasseD1999Spatial distribution of human liver aldehyde dehydrogenase isoenzymes.111461466YinSJLiaoCSLeeYCWuCWJaoSW1994Genetic polymorphism and activities of human colon alcohol and aldehyde dehydrogenases: no gender and age differences.1812561260PorterMMStuartSBoijMLexellJ2002Capillary supply of the tibialis anterior muscle in young, healthy, and moderately active men and women.9214511457DuschaBDAnnexBHKeteyianSJGreenHJSullivanMJ2001Differences in skeletal muscle between men and women with chronic heart failure.90280286HollowayGPPerryCGThrushABHeigenhauserGJDyckDJ2008PGC-1alpha's relationship with skeletal muscle palmitate oxidation is not present with obesity despite maintained PGC-1alpha and PGC-1beta protein.294E10601069StaronRS1997Human skeletal muscle fiber types: delineation, development, and distribution.22307327WangYXZhangCLYuRTChoHKNelsonMC2004Regulation of muscle fiber type and running endurance by PPARdelta.2e294GrimaldiPA2003Roles of PPARdelta in the control of muscle development and metabolism.3111301132LuquetSLopez-SorianoJHolstDFredenrichAMelkiJ2003Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability.1722992301LinJWuHTarrPTZhangCYWuZ2002Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres.418797801NorrbomJSundbergCJAmelnHKrausWEJanssonE2004PGC-1alpha mRNA expression is influenced by metabolic perturbation in exercising human skeletal muscle.96189194PilegaardHSaltinBNeuferPD2003Exercise induces transient transcriptional activation of the PGC-1alpha gene in human skeletal muscle.546851858RussellAPFeilchenfeldtJSchreiberSPrazMCrettenandA2003Endurance training in humans leads to fiber type-specific increases in levels of peroxisome proliferator-activated receptor-gamma coactivator-1 and peroxisome proliferator-activated receptor-alpha in skeletal muscle.5228742881Gonzalez-CadavidNFTaylorWEYarasheskiKSinha-HikimIMaK1998Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting.951493814943GrobetLPirottinDFarnirFPonceletDRoyoLJ2003Modulating skeletal muscle mass by postnatal, muscle-specific inactivation of the myostatin gene.35227238LeeSJ2004Regulation of muscle mass by myostatin.206186NagyTRGoranMIWeinsierRLTothMJSchutzY1996Determinants of basal fat oxidation in healthy Caucasians.8017431748TarnopolskyMAAtkinsonSAPhillipsSMMacDougallJD1995Carbohydrate loading and metabolism during exercise in men and women.7813601368TarnopolskyMABosmanMMacdonaldJRVandeputteDMartinJ1997Postexercise protein-carbohydrate and carbohydrate supplements increase muscle glycogen in men and women.8318771883